Long-term nature of depression

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 14, 1999, Pages 3-9

  Thase, Michael E ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN FUNCTION; CONFERENCE PAPER; DEPRESSION; FAMILY; HUMAN; JOB PERFORMANCE; PRIORITY JOURNAL; PSYCHOTHERAPY; SOCIAL STATUS;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; FAMILY HEALTH; HUMANS; LIFE TABLES; MIDDLE AGED; PATIENT EDUCATION; PSYCHOTHERAPY; RECURRENCE; TREATMENT OUTCOME;

EID: 0032870637     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (53)

1. Murray CJL, Lopez AD. Evidence-based health policy: lessons from the Global Burden of Disease Study. Science 1996;274:740-741
2. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale to consensus definitions of terms in major depressive disorder: response, remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991;48: 851-855
3. Simons AD, Murphy GE, Levine JI, et al. Cognitive therapy and pharmacotherapy for depression: sustained improvement over one year. Arch Gen Psychiatry 1986;43:43-48
4. Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992;49:809-816
5. Thase ME, Simons AD, McGeary J, et al. Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. Am J Psychiatry 1992;149:1046-1052
6. Hirschfeld RMA, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement of depression. JAMA 1997;277:333-340
7. Thase ME. Antidepressant treatment of dysthymia and related chronic depressions. Curr Opin Psychiatry 1998;11:77-83
8. Keller MB, Boland RJ. Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol Psychiatry 1998;44:348-360
9. Judd LL. The clinical course of unipolar major depressive disorders. Arch Gen Psychiatry 1997;54:989-991
10. Zis AP, Goodwin FK. Major affective disorders as a recurrent illness: a critical review. Arch Gen Psychiatry 1979;36:835-839
11. Angst J. The course of affective disorders. Psychopathology 1986;19 (suppl 2):47-52
12. Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990;47: 1093-1099
13. Kupfer DJ, Frank E, Perel JM, et al. Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1992;49:769-773
14. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992;149:999-1010
15. Meador-Woodruff JH, Greden JF, Grunhaus L, et al. Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation: identification of contributing factors. Acta Psychiatr Scand 1990;81:364-371
16. Thase ME, Kupfer DJ, Buysse DJ, et al. Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression, I: comparison during acute depressive states. Biol Psychiatry 1995;38:506-515
17. Kovacs M, Devlin B, Pollock M, et al. A controlled family history study of childhood-onset depressive disorder. Arch Gen Psychiatry 1997;54: 613-623
18. Rosenzweig A, Prigerson H, Miller MD, et al. Bereavement and late-life depression: grief and its complications in the elderly. Annu Rev Med 1997;48:421-428
19. Weissman MM, Merikangas KR, John K, et al. Family-genetic studies of psychiatric disorders. Arch Gen Psychiatry 1986;43:1104-1116
20. Akiskal HS, Walker P, Puzantian VR, et al. Bipolar outcome in the course of depressive illness: phenomenologic, familial, and pharmacologic predictors. J Affect Disord 1983;5:115-128
21. Klein DN, Taylor EB, Dickstein S, et al. The early-late onset distinction in DSM-III-R dysthymia. J Affect Disord 1988;14:25-33
22. Klerman GL, Weissman MM. Increasing rates of depression. JAMA 1989; 261:2229-2235
23. Thase ME. The role of axis II comorbidity in the management of patients with treatment resistant depression. Psychiatr Clin North Am 1996;19: 287-309
24. Alexopoulos GS, Meyers BS, Young RC, et al. "Vascular depression" hypothesis. Arch Gen Psychiatry 1997;54:915-922
25. Terman M, Terman JS, Quitkin FM, et al. Light therapy for seasonal affective disorder: a review of efficacy. Neuropsychopharmacology 1989;2:1-22
26. Thase ME. Comparison of seasonal affective disorder with other forms of recurrent depression. In: Rosenthal N, Blehar M. eds. Seasonal Affective Disorders. New York, NY: Guilford Press: 1985:64-78
27. Prien RF, Kupfer DJ. Continuation drug therapy for major depressive episodes: how long should it be maintained? Am J Psychiatry 1986;143: 18-23
28. Depression Guideline Panel. Clinical Practice Guideline Number 5: Depression in Primary Care, vol 2. Treatment of Major Depression. Rockville, Md: US Dept Health Human Services, Agency for Health Care Policy and Research; 1993. AHCPR publication 93-0551
29. American Psychiatric Association. Practice Guideline for Major Depressive Disorder in Adults. Am J Psychiatry 1993;150(suppl 4):1-26
30. Montgomery SA. Efficacy and long-term treatment of depression. J Clin Psychiatry 1996;57(suppl 2):24-30
31. Sackeim H, Prudic J, Devanand DP, et al. The impact of medication resistance and continuation pharmacotherapy on relapse following response to ECT in major depression. J Clin Psychopharmacol 1990;10:96-104
32. Evans MD, Hollon SD, DeRubeis RJ, et al. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry 1992;49:802-808
33. Prien RF, Kupfer DJ, Mansky PA, et al. Drug therapy in prevention of recurrences in unipolar and bipolar affective disorders: report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 1984; 41:1096-1104
34. Kocsis JH, Friedman RA, Markowitz JC, et al. Maintenance therapy for chronic depression: a controlled clinical trial of desipramine. Arch Gen Psychiatry 1996;53:769-776
35. Stewart JW, Tricamo, E, McGrath PJ, et al. Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission. Am J Psychiatry 1997;154:31-36
36. Keller MB, Kocsis JH, Thase ME, et al, for the Sertraline Chronic Depression Study Group. Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA 1998;280:1665-1672
37. Georgotas A, McCue RE, Cooper TA. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry 1989;46:783-786
38. Old Age Depression Interest Group. How long should the elderly take antidepressants? a double-blind placebo-controlled study of continuation/ prophylaxis therapy with dothiepin. Br J Psychiatry 1993;162:175-182
39. Young EA. Glucocorticoid cascade hypothesis revisited: role of gonadal steroids. Depression 1995;3:20-27
40. Reynolds CF III, Frank E, Perel JM, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 1999; 281:39-45
41. Montgomery SA, Dufour H, Brion S, et al. The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatry 1988;153(suppl 3):69-76
42. Stewart JW, Quitkin FM, McGrath PJ, et al. Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo. Arch Gen Psychiatry 1998; 55:334-343
43. Franchini L, Gasperini M, Perez J, et al. A double-blind study of long-term treatment with sertraline or fluvoxamine for prevention of highly recurrent unipolar depression. J Clin Psychiatry 1997;58:104-107
44. Quitkin FM, Rabkin JD, Markowitz JM, et al. Use of pattern analysis to identify true drug response. Arch Gen Psychiatry 1987;44:259-264
45. Basco MR, Rush AJ. Compliance of pharmacotherapy in mood disorder. Psychiatr Ann 1995;25:269-270, 276-279
46. Kupfer DJ, Perel JM, Frank E. Adequate treatment with imipramine in continuation treatment. J Clin Psychiatry 1989;50:250-255
47. Kupfer DJ, Frank E, McEachran AB, et al. Delta sleep ratio: a biological correlate of early recurrence in unipolar disorder. Arch Gen Psychiatry 1990;47:1100-1105
48. Frank E, Kupfer DJ, Wagner EF, et al. Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression: contributing factors. Arch Gen Psychiatry 1991;48:1053-1059
49. Spanier C, Frank E, McEachran AB, et al. The prophylaxis of depressive episodes in recurrent depression following discontinuation of drug therapy: integrating psychological and biological factors. Psychol Med 1996;26:461-475
50. Thase ME. Relapse and recurrence in unipolar major depression: short-term and long-term approaches. J Clin Psychiatry 1990;51(6, suppl):51-57
51. Frank E, Kupfer DJ, Perel JM, et al. Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression. J Affect Disord 1993;27:139-145
52. Fava GA, Grandi S, Zielezny M, et al. Cognitive behavioral treatment of residual symptoms in primary major depressive disorders. Am J Psychiatry 1994;151:1295-1299
53. Fava GA, Grandi S, Zielezny M, et al. Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 1996;153:945-947